Evidence map›Paper›PMID 37142797›Full record

Article3D printing in medicine2023

Perspectives on medical 3D printing at the point-of-care from the new European 3D Printing Special Interest Group.

Giovanni Biglino, Carina Hopfner, Joakim Lindhardt, Francesco Moscato, Josep Munuera, Gunpreet Oberoi, Alessandro Tel, Arnau Valls Esteve

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3D printing in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giovanni BiglinoBristol Medical School, University of Bristol, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK. g.biglino@bristol.ac.uk.
Carina HopfnerDepartment of Pediatric Cardiology & Pediatric Intensive Care Medicine, LMU Klinikum, Munich, Germany.
Joakim Lindhardt3D Printing Center, Aarhus Universitetshospital, Aarhus, Denmark.
Francesco MoscatoCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Josep Munuera3D Unit (3D4H), Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
Gunpreet OberoiCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Alessandro TelUniversity Hospital of Udine, Head & Neck and Neuroscience Department, Clinic of Maxillofacial Surgery, Udine, Italy.
Arnau Valls Esteve3D Unit (3D4H), Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This editorial presents the vision for the newly formed (2022) European 3D Special Interest Group (EU3DSIG) in the landscape of medical 3D printing. There are four areas of work identified by the EU3DSIG in the current landscape, namely: 1) creating and fostering communication channels among researches, clinicians and industry, 2) generating awareness of hospitals point-of-care 3D technologies; 3) knowledge sharing and education; 4) regulation, registry and reimbursement models.

Identifiers

PMID37142797
PMCPMC10159822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.